Abstract:Abstract How Merlin-intact meningiomas arise in the absence of NF2/Merlin inactivation is incompletely understood. Here, we integrate single-cell RNA sequencing of 86,000 cells from meningioma xenografts with APEX2 proteomic proximity-labelling mass spectrometry and functional biochemical approaches to discover Merlin Serine 13 (S13) dephosphorylation drives meningioma Wnt signalling and cell proliferation. Cell biology, molecular biology, and biochemical techniques were used to validate Merlin functions in meningioma cells or xenografts using wildtype Merlin constructs or Merlin constructs encoding S13A, phosphomimetic S13D, or cancer-associated missense substitutions (L46R, A211D). Single-cell RNA sequencing of meningioma xenografts showed Merlin rescue activated the Wnt pathway in Merlin-deficient meningiomas. Proteomic proximity-labelling mass spectrometry revealed b-catenin, PKC, and PP1A interactions with wildtype Merlin, but not with Merlin L46R or A211D. b-catenin does not interact with other FERM family members, and Merlin contains a unique N-terminal domain (NTD) with a PKC phosphorylation motif overlapping with a PP1A dephosphorylation motif at S13. Thus, we hypothesized the Merlin S13, PKC, and PP1A may be important for Wnt signalling in Merlin-intact meningiomas. In support of this hypothesis, over-expression of wildtype Merlin or Merlin S13A but not Merlin DNTD, S13D, L46R, A211D, or other FERM family members drove meningioma Wnt signalling and sustained meningioma cell proliferation in vivo. Moreover, b-catenin was detected in proximity to Merlin S13D but not Merlin S13A in meningioma cells. Meningioma cell fractionation and immunofluorescence showed Merlin S13D over-expression stabilized b-catenin at the plasma membrane and inhibited Wnt signalling. Phospho-proteomic mass spectrometry and custom phospho-specific antibodies integrated with shRNA or siRNA gene suppression demonstrated PKC phosphorylated Merlin S13, but meningioma Wnt pathway activation induced PP1A to dephosphorylate Merlin S13 and drive cell proliferation. In summary, Merlin S13 dephosphorylation drives meningioma Wnt signalling and cell proliferation. These data reveal a novel tumor-promoting function of NF2/Merlin in Merlin-intact meningiomas.

Merlin regulates signaling events at the nexus of development and cancer

The NF2 Tumor Suppressor Merlin Interacts with Ras and RasGAP, Which May Modulate Ras Signaling

Merlin Cooperates with Neurofibromin and Spred1 to Suppress the Ras-Erk Pathway.

Role of Merlin/NF2 inactivation in tumor biology

VprBP Targets Merlin to the Roc1-Cul4A-DDB1 E3 Ligase Complex for Degradation

NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

Tumorigenic Transformation by CPI-17 Through Inhibition of a Merlin Phosphatase.

CSIG-37. MERLIN S13 DEPHOSPHORYLATION DRIVES MENINGIOMA WNT SIGNALLING AND CELL PROLIFERATION

The Tumor Suppressor Merlin Is Required For Cell Cycle Exit, Terminal Differentiation, And Cell Polarity In The Developing Murine Lens

Angiomotin Binding-Induced Activation of Merlin/NF2 in the Hippo Pathway

Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated Schwann cell proliferation in human.

Gatekeeping role of Nf2 /Merlin in vascular tip EC induction through suppression of VEGFR2 internalization

P53 Performs an Essential Role in Mediating the Oncogenic Stimulus Triggered by Loss of Expression of Neurofibromatosis Type 2 During in Vitro Tumor Progression.

NEDD 4L‐mediated Merlin ubiquitination facilitates Hippo pathway activation

Cell-cell adhesion regulates Merlin/NF2 interaction with the PAF complex

Nf2/Merlin is Required for the Axial Pattern Formation in the Xenopus Laevis Embryo

Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma

MerlinS13 phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features

Cnsc-10. When Good Things Go Off Trk: The Intersection Of Neuroscience & Oncology

Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2

Hippo pathway inactivation through subcellular localization of NF2/merlin in outer cells of mouse embryos